Introduction
============

Alcoholism or alcohol dependence is a chronic, progressive disease which results from an inability to regulate drug-seeking behavior. Approximately 17 million Americans are dependent on alcohol ([@B36]), resulting in significant legal and medical costs to society totaling an estimated \$184 billion per year ([@B22]). At present, only disulfiram, naltrexone, and acamprosate are approved by the Food and Drug Administration to treat alcoholism. However, the ability of these medications to reduce the risk of relapse is modest ([@B18]; [@B53]) and thus there is a need to develop more targeted pharmacological treatments for alcohol addiction.

Animal models of relapse permit the identification of the underlying neurobiology of alcohol relapse in humans and thus the targeted development of pharmacotherapies. Relapse is modeled in animals with the reinstatement paradigm, where animals are trained to self-administer drug in an operant chamber. The drug-seeking response is extinguished and reinstated with one of the stimuli known to cause relapse in humans such as stress, cues associated with drug delivery, or the drug itself ([@B14]). It has proven challenging to get laboratory rats to voluntarily consume doses of alcohol relevant to human alcohol addiction. Various procedures have been attempted to increase oral consumption of alcohol in rodents, such as sucrose fading ([@B42]), food and water-deprivation ([@B31]), alcohol vapor exposure ([@B57]; [@B58]), and the use of rat strains selectively bred for high preference to alcohol ([@B43]; [@B56]). Since its introduction in the 1980s, sucrose fading was largely adopted as the chief method of inducing rodents to self-administer alcohol in an operant setting ([@B42]). While sucrose fading yields high alcohol consumption in the presence of sucrose, drinking drops sharply when the sweetener is removed ([@B42]; [@B26]; [@B44]; [@B11]). Additionally, sucrose has addictive properties itself ([@B12]; [@B4]), possibly contributing to the motivation to consume sweetened alcohol. One method of inducing high amounts of unsweetened alcohol consumption in rodents is the intermittent access to alcohol (IAA) procedure in which rodents are provided 24 h access to alcohol followed by a 24 h period with no access ([@B60]; [@B61]; [@B37]). [@B50] recently resurrected this model and induced levels of drinking (20% alcohol v/v) in the 5--8 g/kg/day range in Wistar and Long-Evans strains. Furthermore, [@B49] adapted the IAA paradigm to an operant self-administration model and engendered high levels of alcohol-seeking in the operant chamber after using 14 h operant sessions on intermittent days (MWF), followed by shorter (30--45 min) daily sessions in the operant chamber. Here, we modified this method to eliminate the use of 14 h operant sessions and trained animals in the operant chamber only during daily 45-min sessions for 26 sessions (MTWRF).

We then sought to test the ability of translational compounds which modulate glutamate and/or GABA transmission to attenuate the cue-primed reinstatement of alcohol-seeking. Glutamate transmission in general and specifically in the nucleus accumbens (NAs) and amygdala is strongly implicated in cue-induced alcohol reinstatement. During the cue-primed reinstatement of extinguished operant alcohol-seeking, synaptic glutamate release increases in the NA and the amygdala ([@B16]). Thus, it follows that both systemic and intra-NA or intra-amygdala infusion of antagonists to post-synaptic glutamate receptors attenuate alcohol reinstatement (e.g., [@B6]; [@B5]; [@B46]; [@B51]).

The pharmacological manipulations which prevent relapse to alcohol-seeking also prevent the reinstatement of cocaine-seeking (for review see [@B21]; [@B23]). Following cocaine self-administration and withdrawal, evidence exists for altered glutamate homeostasis, defined as the homeostatic regulation of synaptic and extrasynaptic glutamate levels and signaling. Glutamate homeostasis in the accumbens is complex and regulated by multiple mechanisms, including by the major glutamate transporter GLT-1 and by system x~c~-. System x~c~- exchanges extracellular cystine for intracellular glutamate, thereby contributing the majority of basal extrasynaptic glutamate in the accumbens ([@B9]). The catalytic subunit of system x~c~- is the protein xCT and the hallmarks of altered glutamate homeostasis after cocaine include a reduction in expression and function of both GLT-1 and xCT/system x~c~- ([@B24]; [@B55]). Based on the widespread involvement of various types of glutamate receptors in alcohol relapse, it is likely that glutamate homeostasis is altered following alcohol consumption as well.

Modulation of GABA transmission also impacts alcohol consumption and reinstatement. GABA~A~ antagonists and inverse agonists decrease alcohol consumption (see review by [@B29]) and operant self-administration of alcohol ([@B45]).The GABA~B~ (autoreceptor) agonist baclofen decreases self-administration in non-dependent rats ([@B20]). Conversely, allopregnanolone, an endogenous neurosteroid which has also been shown to be a potent positive modulator of GABA~A~ receptors, dose-dependently induces the reinstatement of alcohol-seeking ([@B35]; [@B15]).

We hypothesized that glutamate homeostasis is altered post-alcohol administration, and restoring homeostasis would reverse alcohol-induced plasticity and thereby attenuate the reinstatement of alcohol-seeking. It is possible to restore glutamate homeostasis and reverse cocaine-induced pathologies in synaptic plasticity following with *N*-acetylcysteine (NAC; [@B33], [@B34]) or ceftriaxone (CEF; [@B55]) and here we tested their ability to attenuate cue-primed reinstatement of alcohol-seeking. NAC serves as a cystine prodrug that drives system x~c~- to export more glutamate while CEF is an antibiotic that upregulates the expression of both GLT-1 ([@B27]) and xCT ([@B28]) at the transcriptional level. We also hypothesized the antibiotic cefazolin (CEFAZ), which has been demonstrated to inhibit GABA~A~ transmission ([@B62]; [@B54]), would attenuate cue-primed alcohol reinstatement. In order to investigate a possible effect of CEFAZ on glutamate homeostasis, we tested its ability to attenuate the reinstatement of cocaine-seeking, a behavior that is dependent on altered glutamate release, clearance and basal levels (for review see [@B23]).

Materials and Methods {#s1}
=====================

Animals and Housing
-------------------

Adult male Sprague-Dawley rats (*n* = 84), weighing 250--275 g upon arrival were individually housed in ventilated Plexiglas cages in a climate-controlled room on a 12-h reverse light/dark cycle (lights off at 9 AM) and given at least 1 week to acclimate to the individual housing conditions and handling. Rats were provided ad libitum water throughout the experiment and were food-deprived to ∼85% of free-feeding weight with a daily allowance of 20 g of food. Food-restriction generally increases responding without altering reinstatement relative to non-restricted controls ([@B10]). Experiment 1 was conducted at the Medical University of South Carolina and Experiments 2--4 were conducted at the University of Florida. All procedures were pre-approved by the Medical University of South Carolina and University of Florida Institutional Animal Care and Use Committees and were in accordance with National Institutes of Health *Guide for the Care and Use of Laboratory Animals*.

Operant Chambers and Training
-----------------------------

Prior to beginning operant self-administration (Experiments 1--4), animals underwent a single, overnight food-training session in the operant chambers where presses on the active lever resulted in the delivery of food pellets. Operant chambers (Med Associates) were equipped with two retractable levers, stimulus lights, and tone generators. On the day following food training, animals were trained to self-administer alcohol, cocaine, or food pellets in the operant chamber. For the food self-administration study (Experiment 3), presses on the active lever delivered food pellets. For drug self-administration studies, presses on the active lever activated a pump which dispensed drug. For alcohol studies (Experiments 1 and 2), 0.1 mL alcohol (20% v/v) was dispensed into a dipper tray; infrared sensors verified head entry into the trough area to consume the alcohol. For the cocaine study (Experiment 4), 0.25 mg cocaine HCl (kindly provided by NIDA) in 0.1 mL 0.9% saline was delivered per infusion. For both cocaine and alcohol studies, drug delivery was accompanied by the presentation of discrete cues (a light and 2900 Hz tone) and for cocaine self-administration, was followed by a timeout (20 s) during which time presses on the active lever did not yield drug. Inactive lever presses had no consequences, but were recorded. For alcohol self-administration, the trough was blotted with a tissue at the end of the session to verify that all alcohol was consumed. Rats who habitually did not consume alcohol despite lever presses were eliminated from the experiment (*n* = 3 for Experiment 1; *n* = 2 for Experiment 2). Additionally, three rats that were in ill-health were removed from Experiments 1 and 2. For both alcohol and cocaine self-administration studies, animals self-administered drug for a pre-determined number of days in the operant boxes (26 for alcohol; 12 for cocaine) regardless of whether drug intake was stable or not. This method was chosen because we wanted to prevent animals from self-administering drug for varying amounts of time which could lead to a wide range of drug intake. The amount of cocaine consumed during self-administration has been correlated with later drug-seeking during reinstatement tests (e.g., [@B13]; [@B8]).

Alcohol Self-Administration, Extinction Training, and Reinstatement Testing
---------------------------------------------------------------------------

All rats that later self-administered alcohol in the operant chambers were first trained to drink with the IAA (e.g., [@B50]). This paradigm provides rats with 24-h access to unsweetened 20% alcohol on alternating days (3 days/weeks) without water-deprivation. Animals experienced 12 sessions (over 4 weeks) of the intermittent-access drinking paradigm.

Following exposure to alcohol using the IAA, animals were trained to self-administer 20% alcohol (v/v) using daily 45 min training sessions on an FR-1 schedule of reinforcement for 6 days followed by an FR-3 schedule for 20 daily sessions. This procedure followed that of [@B49], with the exception of using 45 min FR-3 operant sessions in place of 30 min sessions and replacing the 12 overnight operant sessions with 12 IAA sessions. Extinction training began following the 20th FR-3 session. During extinction training, presses on the previously active lever no longer provided drug and cue presentation. Extinction training lasted a minimum of 10 sessions and until animals reached the criteria of less than 20 lever responses per session. Once this criteria was reached, animals underwent a 45 min cue-primed reinstatement test during which presses on the previously active lever once again yielded presentation of discrete cues that had been paired with alcohol delivery (stimulus light, tone and the sound of the syringe pump activating). In addition, 2 mL of 20% EtOH was sprinkled on the bedding of the operant chamber to provide an olfactory cue.

### Experiment 1

Here, we tested the ability of chronically administered NAC to attenuate the cue-primed reinstatement of alcohol-seeking. *N*-acetylcysteine (Sigma, 30 or 60 mg/kg IP) or vehicle (VEH; saline 0.3 mL IP) was administered 2 h prior to the last 6--8 extinction sessions and prior to the reinstatement test (see **Figure [1A](#F1){ref-type="fig"}**). The dose and timing of injections was based on previous studies demonstrating the ability of 60 mg/kg NAC to restore basal glutamate levels after cocaine and attenuate cocaine reinstatement when given both acutely prior to testing ([@B7]) and chronically during extinction training ([@B2]) while a lower dose (33 mg/kg) only partially inhibits cocaine-seeking ([@B33]). NAC works acutely, within 2 h of administration, to increase basal glutamate by serving as an exogenous source of cysteine, which drives system x~c~- to export more glutamate ([@B7]), but also alters glutamate homeostasis when administered daily for 5 or more days ([@B24]; [@B2]). After reaching extinction criteria, the responding of the NAC-treated animals during a cue- primed reinstatement trial was compared with VEH-treated animals. Animals were assigned to receive NAC or VEH treatment in a counterbalanced manner to ensure no group differences in drug self-administration. One animal was excluded from reinstatement testing (and all data analysis) due to a failure to reach extinction criteria.

![Experimental Methods. **(A)** Timeline of the experimental procedure for Experiments 1 and 2. All animals were trained to self-administer food pellets immediately prior to beginning operant alcohol self-administration. VEH, NAC, CEF, and CEFAZ treatment commenced on the last 6--8 days of extinction training. For the NAC experiment, animals were also injected 2 h prior to the test. **(B)** Timeline of the experimental procedure for Experiment 3. All animals were trained to self-administer food pellets immediately prior to beginning operant alcohol self-administration. VEH, CEF, and CEFAZ treatment commenced on Day 5 of food self-administration and continued through Day 12. **(C)** Timeline of the procedure for Experiment 4. All animals were trained to self-administer food pellets immediately prior to beginning operant cocaine self-administration. VEH and CEFAZ was administered for the last 6--8 extinction sessions and continued after the cue-primed reinstatement test.](fphar-06-00044-g001){#F1}

### Experiment 2

This experiment was carried out in an identical manner to Experiment 1, with the exception that CEF (Hospira, 200 mg/kg IP), CEFAZ (Sigma, 100 mg/kg IP), or VEH (0.9% saline) were administered immediately following the last 6--8 extinction sessions, but not on test day (see **Figure [1A](#F1){ref-type="fig"}**). After reaching extinction criteria, the responding of the CEF and CEFAZ- treated animals during a cue- primed reinstatement trial was compared with VEH -treated animals. The dose and timing of CEF injections was based on previously published reports showing that 200 mg/kg effectively attenuates cocaine reinstatement and restores glutamate homeostasis when given chronically *after* extinction sessions for at least 5 days ([@B24]; [@B55]). The dose of CEFAZ was based on allometric calculations from the maximum human dose recommended by the manufacturer to the equivalent rat dose of 100 mg/kg maximum and was given after extinction sessions akin to the administration of CEF.

### Food and Sucrose Self-Administration (Experiment 3)

Animals self-administered standard chow pellets (45 mg; Bio-serv) in the operant chamber using an FR-1 schedule of reinforcement for 2 h/day for 12 days. On the 13th day, sucrose pellets (45 mg; Bio-serv) replaced the standard chow pellets. Animals received CEF, CEFAZ, or VEH in an identical manner as described for Experiment 2, with the exception that injections began after the operant session on Day 5 of food self-administration (see **Figure [1B](#F1){ref-type="fig"}**).

### Cocaine Self-Administration, Extinction, and Reinstatement (Experiment 4)

For the implantation of catheters, rats were anesthetized with ketamine HCl (87.5 mg/kg, IM) and xylazine (5 mg/kg, IM). Ketorolac (3 mg/kg, IP) was administered before surgery to provide analgesia. Catheter construction and surgical implantation is described in detail elsewhere ([@B25]). Rats recovered 6 days after surgery prior to beginning self-administration training. Cocaine self-administration was conducted using an FR-1 schedule; sessions lasted 2 h/day and are described in more detail above. Self-administration continued until subjects had attained 12 days with a minimum of 10 cocaine infusions and was followed by extinction training. Animals were either treated with CEFAZ or VEH in manner identical to that in Experiment 2, immediately following the last 6--8 extinction sessions (see **Figure [1C](#F1){ref-type="fig"}**). Once extinction criteria was attained, animals were tested for cue- and cocaine-primed reinstatement (each test lasting 2 h), with tests separated by 3 days of extinction training. During cue-primed reinstatement, presses on the previously active lever once again yielded the discrete cues paired with cocaine delivery but no drug was delivered. During cocaine-primed reinstatement, animals were injected with 10 mg/kg cocaine (IP) immediately prior to being placed into the operant chamber; presses on the previously active lever had no consequences during this test.

Data Analysis
-------------

The alpha level was set at *p* \< 0.05 for all statistical tests, which were conducted using SPSS software. Active lever presses during self-administration and extinction components of the experiment were analyzed with mixed-factorial 2-way analysis of variances (ANOVAs) test, with time as the repeated measure. Reinstatement tests were planned comparisons (extinction vs. test day) and thus were analyzed with paired-sample *t*-tests. Independent-sample *t*-tests were used to compare active lever presses during reinstatement tests between treatment groups. Group differences in food self-administration were examined using one-way ANOVAs. Outliers were defined as values more than two standard deviation +/-- the mean and were excluded from further analysis. Groups with outlier values are mentioned in the Results section.

Results
=======

The Effects of NAC on Cue-Primed Reinstatement of Alcohol-Seeking (Experiment 1)
--------------------------------------------------------------------------------

VEH- and NAC-treated groups did not differ in the amount of alcohol self-administered (**Figure [2A](#F2){ref-type="fig"}**). A two-way ANOVA with repeated measures on Day was computed on the active lever press data during self-administration and found no significant effect of Day \[*F*(19,475) = 1.480, n.s.\], or Group \[*F*(2,25) = 0.080, n.s.\]. There was a significant Day × Group interaction \[*F*(19,475) = 2.020, *p* \< 0.01\]. Similarly, a two-way ANOVA was computed on the lever presses during extinction training (**Figure [2B](#F2){ref-type="fig"}**) and revealed a significant effect of Day \[*F*(9,225) = 6.977, *p* \< 0.001\], but not Group \[*F*(2,25) = 0.240, n.s.\]. There was not a significant Day × Group interaction \[*F*(18,225) = 0.809, n.s.\]. We used paired-sample *t*-tests to analyze the data presented in **Figure [2C](#F2){ref-type="fig"}** to compare active lever presses during cue-primed reinstatement to those during the average of the last 3 days of extinction. Significant differences were found between extinction and cue-primed reinstatement for all treatment groups \[Veh: *t*(1,7) = 4.036, *p* \< 0.01; NAC60: *t*(1,8) = 4.302, *p* \< 0.01; NAC30: *t*(1,9) = 3.651, *p* \< 0.05\], indicating that neither dose of NAC was able to prevent cue-primed reinstatement of alcohol-seeking.

![*N*-acetylcysteine did not attenuate cue-primed reinstatement of alcohol-seeking. **(A)** Mean active lever presses during the FR3 portion of the experiment did not differ between groups. **(B)** Mean active lever presses during extinction training did not differ between groups. **(C)** *N*-acetylcysteine did not attenuate cue-primed reinstatement of alcohol-seeking. \**p* \< 0.05 comparing extinction to test.](fphar-06-00044-g002){#F2}

The Effects of CEF and CEFAZ on Cue-Primed Reinstatement of Alcohol-Seeking (Experiment 2)
------------------------------------------------------------------------------------------

Vehicle, CEF, and CEFAZ groups did not differ in the amount of active lever presses during self-administration (**Figure [3A](#F3){ref-type="fig"}**). A two-way ANOVA with repeated measures on Day was computed on the active lever presses during alcohol self-administration (**Figure [3A](#F3){ref-type="fig"}**) and revealed a significant effect of Day \[*F*(19,380) = 2.612, *p* \< 0.01\], but not Group \[*F*(2,20) = 0.370, n.s.\]. There was not a significant Day × Group interaction \[*F*(19,380) = 1.277, n.s.\]. Similarly, a two-way ANOVA was computed on the number of lever presses during extinction training (**Figure [3B](#F3){ref-type="fig"}**) and revealed a significant effect of Day \[*F*(9,180) = 8.050, *p* \< 0.001\], but not Group \[*F*(2,20) = 0.989, n.s.\]. There was not a significant Day × Group interaction \[*F*(2,180) = 1.249, n.s.\]. We used paired-sample *t*-tests to compare active lever presses during cue-primed reinstatement to those during the last 3 days of extinction (**Figure [3C](#F3){ref-type="fig"}**). A significant difference between extinction and cue-primed reinstatement was only observed for vehicle-treated animals \[*t*(1,8) = 2.892, *p* \< 0.05\], indicating that CEF \[*t*(1,6) = 1.3998, n.s.\] and CEFAZ \[*t*(1,6) = 2.090, n.s.\] attenuated cue-primed reinstatement of alcohol-seeking.

![Ceftriaxone and cefazolin attenuated the reinstatement alcohol-seeking.**(A)** Mean active lever presses during the FR3 portion of the experiment did not differ between groups. **(B)** Mean active lever presses during extinction training did not differ between groups. **(C)** Only vehicle-treated animals reinstated lever-pressing during a cue-primed reinstatement test. \**p* \< 0.05 comparing extinction to test.](fphar-06-00044-g003){#F3}

CEF and CEFAZ Did Not Alter Food and Sucrose Self-Administration or Weight (Experiment 3)
-----------------------------------------------------------------------------------------

Because CEF and CEFAZ treatment commenced following the session on Day 5, statistical analyses were conducted only on the data during the period of antibiotic (or vehicle) treatment (Days 6--12). One animal was excluded from data analysis because his lever pressing on Day 13 was greater than two standard deviations from the mean value. A one-ANOVA was computed on active lever presses during self-administration and revealed no effect of treatment group \[*F*(2,17) = 2.128, n.s.; **Figure [4A](#F4){ref-type="fig"}**\]. We also conducted a two-way ANOVA with repeated measures on Day and this analysis revealed no significant effects \[Day: *F*(6,102) = 1.963, n.s.; Day × Group: *F*(12,102) = 1.375, n.s.; Group: *F*(2,17) = 2.361, n.s.\]. A one-way ANOVA was used to determine if there were group differences in the number of sucrose pellets earned on Day 13 of the experiment (**Figure [4B](#F4){ref-type="fig"}**) and found no effect \[*F*(2,17) = 1.068, n.s.\]. There was also no difference in weight over time between the three treatment groups (**Figure [4C](#F4){ref-type="fig"}**). A two-way RM ANOVA found an effect of Day \[*F*(11,102) = 9.145, *p* \< 0.001\] but no Day × Group interaction \[*F*(12,102) = 2.507, n.s.\] or effect of Group \[*F*(2,17) = 1.924, n.s.\] on animal weight.

![Ceftriaxone and cefazolin did not alter the motivation to self-administer regular chow or sucrose pellets. **(A)** CEF and CEFAZ did not alter the self-administration of regular chow pellets. **(B)** CEF and CEFAZ did not alter the mean number of sucrose pellets self-administered. **(C)** Mean body weight did not differ between vehicle-, CEF- or CEFAZ-treated rats.](fphar-06-00044-g004){#F4}

CEFAZ Did Not Attenuate the Reinstatement of Cocaine-Seeking (Experiment 4)
---------------------------------------------------------------------------

A two-way ANOVA computed on the amount of cocaine intake (**Figure [5A](#F5){ref-type="fig"}**) revealed no group differences \[*F*(1,12) = 0.357, n.s.\], no effect of Day \[*F*(11,132) = 1.562, n.s.\], and no Day × Group interaction \[*F*(12,132) = 0.453, n.s.\]. There were also no group differences in extinction training \[*F*(1,12) = 0.472, n.s.\] and no Day × Group interaction \[*F*(12,108) = 0.696, n.s.\] but there was an effect of Day \[*F*(9,108) = 19.076, *p* \< 0.001\] as both groups decreased lever pressing during the course of training (**Figure [5B](#F5){ref-type="fig"}**). Paired-sample *t*-tests revealed significant differences between extinction and cue-primed reinstatement for both CEFAZ \[*t*(1,5) = 2.834, *p* \< 0.05\] and vehicle-treated \[*t*(1,7) = 4.453, *p* \< 0.01\] animals (**Figure [5C](#F5){ref-type="fig"}**). Paired-sample *t*-tests revealed significant differences between extinction and cocaine-primed reinstatement for both CEFAZ \[*t*(1,5) = 2.834, *p* \< 0.05\] and vehicle-treated \[*t*(1,7) = 2.614, *p* \< 0.05\] animals (**Figure [5D](#F5){ref-type="fig"}**). Thus, CEFAZ did not attenuate cue- or cocaine-primed reinstatement. Furthermore, an independent sample *t*-test showed no lever pressing differences between vehicle- and CEFAZ-treated groups during the cue \[*t*(1,12) = 0.272, n.s.\] and cocaine tests\[*t*(1,12) = 0.269, n.s.\].

![Cefazolin did not attenuate cue- or cocaine-primed reinstatement of cocaine-seeking. **(A)** Animals later treated with vehicle or CEFAZ did not differ in the number of infusions attained during cocaine self-administration. **(B)** Vehicle- and CEFAZ-treated animals did not differ in active lever presses during extinction training. **(C)** CEFAZ did not attenuate cue-primed reinstatement. **(D)** CEFAZ did not attenuate cocaine-primed reinstatement. \**p* \< 0.05 comparing extinction to test.](fphar-06-00044-g005){#F5}

Discussion
==========

Here, we demonstrated that training Sprague-Dawley rodents to self-administer unsweetened alcohol in the operant chamber can be accomplished using daily training sessions without lengthy (14 h; e.g., [@B49]) operant sessions on alternating days. This is the first demonstration of such an effect in the Sprague-Dawley strain. [@B3] recently demonstrated the same effect in Wistar rats. Using the procedure outlined here (**Figure [1A](#F1){ref-type="fig"}**) reduced the time to complete the experiment by 4 weeks relative to a procedure utilizing intermittent (MWF) operant sessions (e.g., [@B49]). This represents a significant conservation of lab resources.

We used this operant procedure to investigate the ability of NAC, CEF, and CEFAZ to attenuate cue-primed reinstatement. Five days of NAC treatment (30 or 60 mg/kg) did not attenuate cue-primed reinstatement (**Figure [2C](#F2){ref-type="fig"}**). We found that chronic CEF (200 mg/kg) and CEFAZ (100 mg/kg) attenuated cue-primed reinstatement of alcohol-seeking (**Figure [3C](#F3){ref-type="fig"}**). Both NAC and CEF attenuate cocaine and heroin reinstatement ([@B7]; [@B64]; [@B24]; [@B40]; [@B52]; [@B48]). Furthermore, both compounds have been documented to similarly restore glutamate homeostasis in the NAc following cocaine (see **Table [1](#T1){ref-type="table"}**). Both compounds increase GLT-1 and system x~c~-/xCT expression and function ([@B24]; [@B55]), increase basal glutamate levels ([@B7]; [@B55]), and normalize potentiated glutamate synapses ([@B34]; [@B55]). Because CEF and NAC modulate post-cocaine glutamate homeostasis in similar manner, and the present results reveal a dissociation between the ability of the compounds to attenuate alcohol reinstatement, CEF and CEFAZ likely attenuate alcohol reinstatement via a glutamate-independent mechanism.

###### 

Summary of *N*-acetylcysteine and ceftriaxone effects on cocaine-induced adaptations in the nucleus accumbens.

  Post-cocaine adaptation                            Compound                                        
  -------------------------------------------------- ----------------------------------------------- --------------------
  Restore (elevate) basal glutamate                  Yes [@B7]                                       Yes [@B55]
  Prevent glutamate release during cocaine relapse   Yes [@B7]                                       Yes [@B55]
  Increase GLT-1 expression/function                 Yes (expression) [@B24] function not assessed   Yes [@B24], [@B55]
  Increase xCT expression/system xc- function        Yes [@B7], [@B24]                               Yes [@B24], [@B55]
  Stimulate mGluR2/3 function                        Yes [@B34]                                      Not yet assessed
  Normalize potentiated accumbens synapses           Yes [@B34]                                      Yes [@B55]

Cefazolin has been shown to reduce GABA~A~ transmission ([@B62]; [@B54]). Positive allosteric modulation of GABA~A~ enhances reinstatement of alcohol-seeking ([@B15]; [@B38]) and thus a reduction in GABA transmission by CEFAZ may be the mechanism of action by which it reduces alcohol reinstatement. CEF has not been fully evaluated for its ability to alter GABA transmission although one report exists showing that it does not alter GABA~A~ receptor binding in the hippocampus or frontal and parietal cortices ([@B19]). CEFAZ has not been demonstrated to alter glutamate transmission: it does not alter NMDA function ([@B62]; [@B54]) and was not determined to potently induce GLT-1 expression as do CEF and penicillin ([@B41]). The data presented in **Figures [5C, D](#F5){ref-type="fig"}** provide evidence that CEFAZ does not alter cue- or cocaine-primed reinstatement of cocaine-seeking. Thus, the mechanism by which CEFAZ attenuates alcohol reinstatement likely does not involve modulation of glutamate neurotransmission in the NAs.

Ceftriaxone and CEFAZ are antibiotics and have the potential to produce gastrointestinal distress upon chronic administration. Oral alcohol self-administration in rodents and even alcohol-seeking during cue-primed reinstatements tests may be impacted by this side-effect. Thus we sought to determine the effects of these antibiotics on the operant self-administration of regular chow and sucrose pellets. We found no effect of either antibiotic on the self-administration of chow (**Figure [4A](#F4){ref-type="fig"}**) or sucrose (**Figure [4B](#F4){ref-type="fig"}**) pellets or on body weight during the course of CEF and CEFAZ injections (**Figure [4C](#F4){ref-type="fig"}**). These findings are in agreement with those of [@B59] who found no effect of CEF on the self-administration of sweet food in mice. Interestingly, the chronic administration of NAC, which did not attenuate alcohol-seeking here, has been demonstrated to reduce operant self-administration of regular chow ([@B39]). Thus, we can conclude that the ability of CEF and CEFAZ to attenuate cue-primed alcohol-seeking is likely not dependent on any gastrointestinal side-effects of these compounds.

Because CEFAZ had no impact on cocaine reinstatement (**Figure [5C](#F5){ref-type="fig"}**), it may not be capable of restoring glutamate homeostasis after cocaine. Thus, this is not likely the mechanism by which CEF and CEFAZ attenuate cue-primed reinstatement of alcohol-seeking. In support of this, NAC, which does alter glutamate homeostasis, did not attenuate cue-primed alcohol-seeking. This conclusion is surprising in light of the evidence supporting glutamate signaling in this behavior. In alcohol-preferring (P) rats, CEF reduces the consumption of alcohol acutely and after a period of withdrawal ([@B47]; [@B1]). In P rats, the ability of CEF to modulate alcohol-seeking was accompanied by increases in GLT-1 and xCT ([@B47]; [@B1]). These results indicate that the modulation of glutamate homeostasis may be the mechanism by which CEF attenuates alcohol consumption, at least in P rats. However, the increased expression of these proteins was not shown to be the mechanism by which CEF exerted its behavioral effects. An alternative explanation for the failure of NAC to attenuate alcohol reinstatement in the present manuscript is that the operationalization of the alcohol-seeking response may have altered the underlying neurobiology of alcohol-seeking, rendering the manipulation of GLT-1 and xCT (and thereby glutamate levels) ineffective at preventing reinstatement.

The lack of an effect of NAC on alcohol-seeking here does not discount the involvement of glutamate in alcohol reinstatement. Antagonism of the post-synaptic mGluR5 and AMPA receptors attenuates cue-induced reinstatement ([@B6]; [@B5]; [@B46]; [@B51]). Stimulating the pre-synaptic glutamate autoreceptor mGluR2/3 also attenuates cue-induced reinstatement of alcohol-seeking ([@B63]), presumably by decreasing pre-synaptic glutamate release. While both cocaine and alcohol reinstatement are driven by synaptic glutamate release in the NA core during the reinstatement event ([@B30]; [@B16]) and NAC and CEF attenuate that increase during *cocaine* reinstatement ([@B7]; [@B55]), NAC (and potentially CEF) may not be able to attenuate glutamate release during *alcohol* reinstatement. The reason for this may be that cocaine and alcohol have opposite effects on basal glutamate levels in the NA core. Cocaine decreases ([@B7]) while alcohol increases ([@B32]; [@B17]) basal glutamate levels. Both NAC and CEF increase basal glutamate levels after cocaine but not in drug-naïve animals

([@B7]; [@B55]). After NAC treatment, this increased basal glutamate derived from system x~c~- restores tone on mGluR2/3 autoreceptors ([@B34]), thereby restoring the ability of these receptors to exert negative feedback on glutamate release during reinstatement. It is possible that increased basal glutamate following alcohol also causes a failure in mGluR2/3 signaling that is insensitive to NAC treatment. The effects of CEF on mGluR2/3 function have not yet been investigated (see **Table [Table 1](#T1){ref-type="table"}**). Future experiments examining basal glutamate levels 2--3 weeks after cessation of alcohol self-administration in combination with NAC and CEF would provide valuable data regarding the potential value in manipulating basal glutamate to treat alcohol relapse.

Overall, these results indicate that training Sprague-Dawley rats to self-administer alcohol in the operant chamber can be accomplished without sucrose fading and by using daily training sessions without lengthy operant sessions. We found that modulating glutamate homeostasis likely will not represent a successful treatment strategy for preventing relapse to alcohol-seeking. Future studies should investigate GABA modulation as a potential mechanism of action for CEF and as a method of attenuating alcohol relapse.
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